openPR Logo
Press release

Cancer Biomarkers Market worth 15,973.8 Million USD by 2020

12-28-2016 10:06 AM CET | Health & Medicine

Press release from: MarketsandMarkets.com

Cancer Biomarkers Market worth 15,973.8 Million USD by 2020

The report “Cancer Biomarker Market by Tumor (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay) Application (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast to 2020”, analyzes and studies the major market drivers, restraints, opportunities, challenges, and trends in North America, Europe, Asia-Pacific, and Rest of the World.

Cancer biomarkers are molecules secreted by a tumor or a specific response of the body to the presence of cancer. These are also referred as substance or processes which are indicative of the presence of cancer in the human body, which enhances the cancer detection and facilitate high speed, non-invasive diagnosis using genomics and proteomics based tools. The cancer biomarkers are used for drug discovery and development, diagnostics, personalized medicine, and therapeutics.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=202

In this report, the cancer biomarkers market is segmented on the basis of type of biomarkers, tumor type, profiling technologies, applications, and region. Based on biomarker type, the market is segmented into protein biomarkers, genetic biomarkers, and others which include viral, cell, and carbohydrate biomarkers. Based on tumor type, the market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, and other type of cancers such as Gastrointestinal Stromal Tumors (GIST), lung, ovarian, bladder, pancreatic, kidney, melanoma, and leukemia cancers. Based on profiling technologies, the market is segmented into omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics. Based on applications, the market is segmented into diagnostics, drug discovery and development, prognostics, risk assessment, and others which include surrogate endpoints, recurrence, personalized medicine, and therapeutics. This report also discusses key market drivers, restraints, opportunities, and challenges for this market and its submarkets. The global cancer biomarkers market is expected to reach USD 15,973.8 Million by 2020, at a CAGR of 11.6% from 2015 to 2020.

The diagnostics segment is the largest application of cancer biomarkers which includes tests that access the biological makeup of individuals at the molecular level to determine the individual’s predisposition to a particular disease or condition and diagnose it. With the introduction of new technologies and applications, this is one of the most rapidly advancing areas of research and medicine. The rising prevalence of cancer; increasing demand for advanced diagnostics tests; increased awareness and acceptance of diagnostics tests; advancement in technologies; and the need for early-stage cancer diagnosis further propels the growth of this market.

In 2014, North America accounted for the largest share of the cancer biomarkers market, followed by Europe, Asia-Pacific, and RoW. The major shares of North America and Europe are primarily attributed to rising prevalence of cancer, faster adoption of advanced technologies like advanced high throughput technologies, increasing research studies on discovery and development of novel biomarkers, presence of large number of pharmaceutical companies, rising funding and investment from public and private organizations, presence of key players in these regions, and rising applications of biomarkers in patient stratification and drug development process. The future growth of the cancer biomarkers market will be driven by the Asia-Pacific region, owing to the rising incidence of cancer in this region, increasing use of biomarker tests for diagnosis purposes, expansions of major pharmaceutical companies in emerging Asian economies, and government support to research institutes and universities. However, poorly suited regulatory and reimbursement systems for biomarker tests and requirement of high capital investments for biomarker discovery and development are expected to restrain the growth of this market during the forecast period.

The prominent players in the cancer biomarkers market are Abbott Laboratories (U.S.), Affymetrix Inc. (U.S.), Roche Diagnostics Ltd. (Switzerland), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands), Agilent Technologies (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck & Co. Inc. (U.S.), Becton Dickinson and Company (U.S.), and Hologic Inc. (U.S.).

About MarketsandMarkets

MarketsandMarkets is world’s No. 1 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market worth 15,973.8 Million USD by 2020 here

News-ID: 402225 • Views:

More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players are Sika (Switzerland), BASF (Germany), MAPEI (Italy), GCP Applied Technologies (US), CEMEX (Mexico), W. R. Meadows (US)
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any

All 5 Releases


More Releases for Markets

Security Inks Markets Experts Tackle Technology, Markets, Supply Chain & More Fo …
"According to the research report, the global security inks market was valued at USD 3.37 billion in 2022 and is expected to reach USD 5.11 billion by 2032, to grow at a CAGR of 4.3% during the forecast period." Polaris Market Research recently launched the latest update on Security Inks Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2032, that gives an extensive outlook of the market,
Nanocellulose: Global Markets
Summary: The global nanocellulose market totaled $REDACTED in 2021 and $REDACTED in 2022. Growing at a CAGR of REDACTED%, the market is expected to reach $REDACTED in 2027. Given the current state of ecological consciousness, it is challenging to disregard dangerous emissions from any industrial process or human activity due to their negative effects on the environment. Recently, several academics have expressed concern about the need to replace input materials with less-
01-18-2022 | Science & Education
SDKI
Contextual Advertising Markets
SDKI Inc. is a contextual advertising market research report aimed at providing a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2018-2023. Was published on April 20, 2021. Report sample URL https://www.sdki.jp/sample-request-109951 The contextual advertising market is estimated to grow from US $ 125.79 billion in 2018 to US $ 297.68 billion by 2023 and is expected to grow at a CAGR of
01-12-2022 | Energy & Environment
SDKI
Distribution Automation Markets
SDKI Inc. is a power distribution automation market research report aimed at providing a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2018-2023. Was published on April 14, 2021. Report sample URL https://www.sdki.jp/sample-request-109977 The distribution automation market is estimated to grow from US $ 11.82 billion in 2018 to US $ 16.81 billion by 2023, with a CAGR of 7.29% during the forecast
Research for Markets
This report studies the Global Light Management System Market, analyzes and researches the Light Management System development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • GE (US) • Philips Lighting (Netherlands) • Eaton (Ireland) • Zumtobel (Austria) • OSRAM (Germany) Looking For More Information on This Market? Get Free Sample Report @ http://www.researchformarkets.com/sample/global-light-management-system-market-35079 Market segment by Regions/Countries,
Cellular M2M Markets
Consistent growth driven mainly by Automotive and Utilities This report analyses the overriding trends and changes taking place in the M2M market around the globe. It explores the driving forces behind the market’s growth and transformation, including an examination of major market trends, plus volume and value forecasts up to 2020 by region (4) and by country (25). It also presents the quantitative evolution of cellular modules, by application and by networking technology.